2021
Clearing the Congestion
Berman J, Lee L, Monga R, Ye K, Sprayregen S, Haramati L. Clearing the Congestion. Journal Of Thoracic Imaging 2021, 38: 18-22. PMID: 34739426, DOI: 10.1097/rti.0000000000000625.Peer-Reviewed Original ResearchConceptsNormal brain natriuretic peptideBrain natriuretic peptideCongestive heart failureHistory of CHFSerum brain natriuretic peptideHigher Body Mass IndexBody mass indexBNP levelsMass indexPresence of CHFHigher serum BNP levelsSerum BNP levelsEmergency department patientsED cohortCXR resultsHeart failureDepartment patientsED patientsStudy cohortNatriuretic peptideClinical dilemmaChest radiographsPatientsCXRLogistic regression
2012
Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D.
Zeidan A, Baer M, Gore S, Sasane M, Paley C, McNally D, Davidoff A. Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D. Blood 2012, 120: 3178. DOI: 10.1182/blood.v120.21.3178.3178.Peer-Reviewed Original ResearchIron chelation therapyCongestive heart failureStudy cohortCardiac conduction disordersMedicare Part DTransfusion thresholdPerformance statusRed blood cellsMyelodysplastic syndromeRenal diseaseConduction disordersChelation therapyObservation periodHistory of CHFPart DCox proportional hazards modelICD-9-CM codesErythropoiesis-stimulating agentsCoronary artery diseaseEntire study cohortMyelodysplastic syndrome patientsEnd of studyProportional hazards modelUtilization patternsMedicare enrollment files
2009
Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program
Krum H, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program. European Journal Of Heart Failure 2009, 11: 542-550. PMID: 19380329, DOI: 10.1093/eurjhf/hfp054.Peer-Reviewed Original ResearchConceptsCongestive heart failureHistory of CHFHazard ratioHeart failureRisk markersRisk factorsIncidence of CHFRisk of CHFMultivariate analysisCox proportional hazards modelNon-steroidal anti-inflammatory drugsBaseline risk factorsHistory of hypertensionEmergency room visitsSignificant risk factorsDose-related increaseSignificant risk markerProportional hazards modelAnti-inflammatory drugsImpact of treatmentEtoricoxib 60CHF hospitalizationBaseline factorsRoom visitsCHF events
2003
Depressive Symptoms and Mortality Two Years After Coronary Artery Bypass Graft Surgery (CABG) in Men
Burg MM, Benedetto C, Soufer R. Depressive Symptoms and Mortality Two Years After Coronary Artery Bypass Graft Surgery (CABG) in Men. Biopsychosocial Science And Medicine 2003, 65: 508-510. PMID: 12883097, DOI: 10.1097/01.psy.0000077509.39465.79.Peer-Reviewed Original ResearchConceptsCoronary artery bypass graft surgeryElevated depressive symptomsDepressive symptomsCardiovascular mortalityTwo-year cardiovascular mortalityArtery bypass graft surgeryHistory of CHFBypass graft surgeryHistory of COPDLong-term mortalityCABG patientsPresurgical symptomsCABG surgeryCardiac mortalityGraft surgeryImportant independent contributorMedical morbidityPathophysiological mechanismsMortality riskIndependent contributorsSymptomsMortalitySurgeryBDI-1Multivariate model
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply